X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2909) 2909
Publication (242) 242
Book Review (57) 57
Book Chapter (7) 7
Book / eBook (3) 3
Conference Proceeding (3) 3
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2442) 2442
oncology (1704) 1704
index medicus (1603) 1603
female (1488) 1488
male (1283) 1283
middle aged (1086) 1086
adult (957) 957
cancer (924) 924
aged (898) 898
chemotherapy (710) 710
risk factors (553) 553
radiotherapy (544) 544
risk (532) 532
care and treatment (497) 497
adolescent (439) 439
treatment outcome (430) 430
retrospective studies (425) 425
child (419) 419
hematology (406) 406
aged, 80 and over (380) 380
research (368) 368
surgery (364) 364
prognosis (353) 353
carcinoma (340) 340
antineoplastic combined chemotherapy protocols - therapeutic use (339) 339
follow-up studies (336) 336
incidence (316) 316
therapy (311) 311
tumors (305) 305
neoplasms, second primary - epidemiology (303) 303
radiology, nuclear medicine & medical imaging (297) 297
health aspects (289) 289
neoplasm staging (283) 283
child, preschool (281) 281
medicine & public health (278) 278
neoplasms, second primary - etiology (265) 265
survival (260) 260
2nd malignancies (256) 256
analysis (251) 251
hematology, oncology and palliative medicine (251) 251
diagnosis (250) 250
2nd malignant neoplasms (246) 246
2nd primary tumors (241) 241
2nd-line treatment (233) 233
radiation (232) 232
combined modality therapy (230) 230
survival rate (230) 230
radiation-therapy (226) 226
survivors (223) 223
young adult (220) 220
disease-free survival (219) 219
children (217) 217
2nd cancers (210) 210
antineoplastic agents - therapeutic use (210) 210
survival analysis (198) 198
breast-cancer (195) 195
long-term survivors (191) 191
squamous-cell carcinoma (191) 191
breast cancer (190) 190
neoplasms (189) 189
follow-up (188) 188
metastasis (188) 188
pediatrics (185) 185
2nd primary malignancies (184) 184
infant (184) 184
oncology, experimental (181) 181
patients (181) 181
time factors (172) 172
2nd primary cancers (170) 170
leukemia (167) 167
radiation therapy (166) 166
antineoplastic combined chemotherapy protocols - adverse effects (164) 164
radiotherapy dosage (158) 158
cohort studies (157) 157
mortality (157) 157
radiotherapy - adverse effects (157) 157
phase-ii trial (154) 154
disease (153) 153
lung cancer (153) 153
epidemiology (151) 151
pharmacology & pharmacy (146) 146
irradiation (144) 144
abridged index medicus (143) 143
acute lymphoblastic-leukemia (142) 142
cisplatin (139) 139
antineoplastic agents - adverse effects (138) 138
neoplasms, radiation-induced - etiology (137) 137
neoplasms, second primary - pathology (136) 136
risk assessment (136) 136
article (132) 132
2nd-line chemotherapy (131) 131
hodgkins-disease (131) 131
management (131) 131
recurrence (131) 131
cancer therapies (129) 129
age factors (128) 128
clinical trials (128) 128
development and progression (123) 123
drug therapy (117) 117
lung neoplasms - pathology (116) 116
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2888) 2888
German (17) 17
French (10) 10
Japanese (7) 7
Polish (4) 4
Spanish (2) 2
Chinese (1) 1
Italian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Upsala Journal of Medical Sciences, ISSN 0300-9734, 2008, Volume 113, Issue 2, pp. 193 - 200
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9871, pp. 1046 - 1057
Journal Article
Journal Article
Blood Reviews, ISSN 0268-960X, 01/2019, Volume 33, pp. 63 - 73
Recent advancements in cancer care, coupled with early detection and an aging population have resulted in significant growth of cancer survivors. Long term... 
Survivorship care plan | Survivorship | Late effects | MULTIPLE-MYELOMA | SECONDARY MALIGNANCIES | BRENTUXIMAB VEDOTIN | CANCER SURVIVORS | TYROSINE KINASE INHIBITORS | NON-HODGKINS-LYMPHOMA | 2ND PRIMARY MALIGNANCIES | QUALITY-OF-LIFE | STEM-CELL TRANSPLANTATION | HEMATOLOGY | CORONARY-ARTERY-DISEASE
Journal Article
JOURNAL OF NUCLEAR MEDICINE, ISSN 0161-5505, 03/2018, Volume 59, Issue 3, pp. 452 - 458
Peptide receptor radionuclide therapy (PRRT) may induce long-term toxicity to the bone marrow (BM). The aim of this study was to analyze persistent hematologic... 
toxicity | SURVIVAL | PRRT | leukemia | RISK | OCTREOTATE | ACUTE MYELOID-LEUKEMIA | MYELODYSPLASTIC SYNDROME | bone marrow | RADIOLABELED SOMATOSTATIN ANALOG | THYROID-CANCER | 2ND PRIMARY MALIGNANCIES | MDS | PHASE-I | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Lu-177-DOTATATE
Journal Article
Journal Article
Journal Article
ENDOCRINE PRACTICE, ISSN 1530-891X, 05/2015, Volume 21, Issue 5, pp. 461 - 467
Objective: Patients with multiple primary malignancies may exhibit unique clinical characteristics that suggest a common predisposition or lead to different... 
PRIMARY TUMORS | WOMEN | PRIMARY CANCERS | METAANALYSIS | ENDOCRINOLOGY & METABOLISM | RISK | 2ND PRIMARY MALIGNANCIES | LINKAGE | BREAST
Journal Article
Swiss medical weekly, ISSN 1424-7860, 2016, Volume 146, p. w14362
Journal Article